Bristol-Myers Squibb (1BMY) Ownership - Who Owns Bristol-Myers Squibb?
Bristol-Myers Squibb (1BMY) Ownership Overview
- 0.03% Insiders
- 18.92% Mutual Funds
- 3.54% Other Institutional Investors
- 28.45% ETFs
- 49.06% Public Companies and Individual Investors
The ownership structure of Bristol-Myers Squibb (IT:1BMY) stock is a mix of institutional, retail, and individual investors. Approximately 50.92% of the company’s stock is owned by Institutional Investors, 0.03% is owned by Insiders, and 49.06% is owned by Public Companies and Individual Investors.
The ownership structure of Bristol-Myers Squibb (IT:1BMY) stock is a mix of institutional, retail, and individual investors. Approximately 50.92% of the company’s stock is owned by Institutional Investors, 0.03% is owned by Insiders, and 49.06% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Sep 09, 2026 | Cristian Massacesi | $403,498 | |
| Aug 25, 2026 | Phil M Holzer | $33,750 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Esl Trust Services, Llc | €37,758 | |
| Dec 31, 2025 | Carolina Wealth Advisors, Llc | €67,425 | |
| Dec 31, 2025 | Pya Waltman Capital, Llc | €201,573 | |
| Dec 31, 2025 | Scs Capital Management Llc | €254,812 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| BlackRock, Inc. | 180,384,994 | Institution | 8.82% | 11,329,981,473 |
| Vanguard | 172,866,769 | Institution | 8.46% | 10,857,761,761 |
| Vanguard Index Funds | 139,572,675 | Institution | 6.83% | 8,766,559,717 |
| Ishares | 102,611,634 | Institution | 5.02% | 6,445,036,732 |
| Spdr | 84,343,358 | Institution | 4.13% | 5,297,606,316 |
| Schwab | 65,209,674 | Institution | 3.19% | 4,095,819,624 |
| Fidelity Concord Street Trust | 35,573,935 | Institution | 1.74% | 2,234,398,857 |
| Theofanis Kolokotrones | 24,923,900 | Institution | 1.22% | 1,565,470,159 |
| Jpmorgan | 23,025,186 | Institution | 1.13% | 1,446,211,933 |
| Invesco | 23,025,149 | Institution | 1.13% | 1,446,209,609 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 139,572,675 | Institution | 6.83% | 8,766,559,717 |
| Fidelity Concord Street Trust | 35,573,935 | Institution | 1.74% | 2,234,398,857 |
| Vanguard Chester Funds | 14,293,460 | Institution | 0.70% | 897,772,223 |
| Vanguard Institutional Index Funds | 12,062,914 | Institution | 0.59% | 757,671,628 |
| Fidelity Salem Street Trust | 11,350,767 | Institution | 0.56% | 712,941,675 |
| Vanguard World Fund | 10,699,694 | Institution | 0.52% | 672,047,780 |
| Tiaa-cref Funds | 8,734,621 | Institution | 0.43% | 548,621,545 |
| Vanguard Whitehall Funds | 8,222,861 | Institution | 0.40% | 516,477,899 |
| Schwab Capital Trust | 7,755,511 | Institution | 0.38% | 487,123,646 |
| Vanguard Fenway Funds | 7,006,777 | Institution | 0.34% | 440,095,663 |
FAQ
Who Owns Bristol-Myers Squibb (IT:1BMY)?
According to the latest TipRanks data, approximately 50.92% of the company's stock is held by institutional investors, 0.03% is held by insiders, and 49.06% is held by public companies and individual investors.
What percentage of Bristol-Myers Squibb (IT:1BMY) stock is held by institutional investors?
According to the latest TipRanks data, approximately 50.92% of Bristol-Myers Squibb (IT:1BMY) stock is held by institutional investors: 18.92% by mutual funds, 28.45% by ETFs and 3.54% by other institutional investors.
What percentage of Bristol-Myers Squibb (IT:1BMY) stock is held by retail investors?
According to the latest TipRanks data, approximately 49.06% of Bristol-Myers Squibb (IT:1BMY) stock is held by public companies and individual investors.
Who owns the most shares of Bristol-Myers Squibb (IT:1BMY)?
BlackRock, Inc. owns the most shares of Bristol-Myers Squibb (IT:1BMY).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
